{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiggnzichgk3owzozqv4kyw5jhbyeuuxfqizl7xop2qrrqqs3n63ki",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlma3vmedm32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihjjtkw2qdmrivvrsxxtpmsn42jcxli5ybszbtzoeied2fqesieam"
    },
    "mimeType": "image/jpeg",
    "size": 95302
  },
  "path": "/news/2026-05-fda-green-bizengri-drug-rare.html",
  "publishedAt": "2026-05-11T17:20:09.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.",
  "title": "FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer"
}